Relay Therapeutics RLAY 深 沪
等待开盘 09-04 09:30:00 美东时间
4.11
+0.450
+12.30%
华盛通- 最 高4.16
- 今 开3.63
- 成交量 262.32万股
- 最 低 3.5844
- 昨 收 3.66
- 总市值 7.03亿
- 52周最高 8.315
- 市盈率 静 --
- 换手率 1.53%
- 52周最低 1.775
- 委 比 -87.62%
- 总股本 1.71亿
- 历史最高 64.37
- 量 比 3.12
- 振 幅 15.73%
- 历史最低 1.775
- 每 手 1
- 风险率 1.55%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股牛股 | 绩优股狂飙！梅西百货大涨超20%，REV Group涨超12%；房地美ADR涨超16%
绩优股狂飙！梅西百货大涨超20%，REV Group涨超12%；房地美ADR涨超16%，美参议院议员敦促特朗普政府暂缓出售公司股份>>
今天 17:12
HC Wainwright & Co. Maintains Buy on Relay Therapeutics, Lowers Price Target to $14
HC Wainwright & Co. analyst Robert Burns maintains Relay Therapeutics (NASDAQ:RLAY) with a Buy and lowers the price target from $16 to $14.
08-26 19:12
美股大行评级 | 潜在涨幅286.44%！RBC Capital上调Edgewise Therapeutics目标价至49美元，维持"跑赢大市"评级
今日重点评级关注：RBC Capital：维持Edgewise Therapeutics"跑赢大市"评级，目标价从48美元升至49美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从6美元升至7美元
08-11 09:43
RLAY stock has given up its prior gain. Relay Therapeutics shares were trading higher after the company reported better-than-expected Q2 financial results.
RLAY stock has given up its prior gain. Relay Therapeutics shares were trading ...
08-08 06:51
Here are the major earnings after the close Thursday
Major earnings expected after the bell on Thursday include: Block (XYZ) Gilead Sciences (GILD) Twilio (TWLO) The Trade Desk (TTD) Main Street Capital Corporation (MAIN) Other earnings slated for rele...
08-07 22:00
Earnings Scheduled For August 7, 2025
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
Preview: Relay Therapeutics's Earnings
Relay Therapeutics (NASDAQ:RLAY) is preparing to release its quarterly earnings...
08-07 02:09
Relay Therapeutics to Announce Second Quarter 2025 Financial Results and Corporate Highlights on August 7, 2025
Relay Therapeutics, a clinical-stage precision medicine company combining cutting-edge computational and experimental technologies, will release its second quarter 2025 financial results and corporate updates after U.S. markets close on August 7, 2025. The company, leveraging its Dynamo® platform to target previously intractable protein targets, focuses on small molecule drug discovery in oncology and genetic diseases.
07-31 20:05
reAlpha Tech Corp. Announces $5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
reAlpha Tech Corp. announced the purchase and sale of 14,285,718 shares of its common stock at $0.35 per share in a registered direct offering under Nasdaq rules. Concurrently, the company will issue unregistered warrants for up to 14,285,718 shares with an exercise price of $0.35 per share, exercisable immediately and expiring in five years. The offering is expected to close on July 22, 2025, subject to customary closing conditions. H.C. Wainwri...
07-21 20:30
reAlpha Enhances Mortgage Operations with AI-Powered Loan Officer Assistant
<p>reAlpha Tech Corp. 推出了AI-powered Internal Loan Officer Assistant，旨在提升抵押贷款处理的效率和准确性。该工具已将手动文档准备时间减少60%，并自动化了三分之一的贷款申请流程。公司CEO Jamie Cavanaugh表示，AI工具不是替代人员，而是帮助专业人士更专注于客户服务。行业数据显示，AI技术可将贷款产量提升50%，缩短审批时间，并降低成本30-50%。reAlpha计划继续扩展AI工具以处理更复杂的抵押贷款场景。</p>
07-02 22:00
